| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bellevue Global Life Science Investors LLC | 88% | $6,125,350 | 2,035,000 | Bellevue Capital Management LLC | 31 Dec 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (% of par) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$164,525 | 0 | |
| 2024 Q4 | 14,270 | $164,525 | -$16,846,131 | 1,146.67% | 3 |
| 2024 Q3 | 1,556,780 | $16,926,798 | -$618,480 | 1,086.5% | 13 |
| 2024 Q2 | 1,616,626 | $17,396,541 | -$16,815,539 | 1,076% | 15 |
| 2024 Q1 | 3,181,098 | $33,912,853 | +$2,360,971 | 1,066% | 23 |
| 2023 Q4 | 0 | $0 | -$176,249 | 0 | |
| 2023 Q3 | 5,539,300 | $57,621,476 | +$9,532,111 | 1,040% | 36 |
| 2023 Q2 | 4,729,193 | $48,522,742 | +$13,422,468 | 1,026.01% | 31 |
| 2023 Q1 | 3,224,140 | $32,560,012 | +$31,920,703 | 1,010% | 22 |